Fig. 5

Relative risks and 95% confidence interval (CI) of two-year mortality associated with different high-sensitivity C-reactive protein (hs-CRP) cut-offs in patients with diabetes mellitus (DM) (blue) and in those without DM (red). Relative risk was adjusted for left ventricular ejection fraction (≤ or > 40%), estimated glomerular filtration rate (≤ or > 60 ml/min/1.73 m²), type of acute myocardial infarction (STEMI vs. NSTEMI) and and prior statin use. The vertical dotted line refers to hs-CRP value of 2 mg/L. The horizontal dotted line refers to the RR associated with hs-CRP value of 2 mg/L in non-DM patients